Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Iomeprol 300 vs Iomeprol 400 in MDCT angiography of peripheral arteries
2005-005946-38Phase 4Completed
- Sponsor
- Bracco Group
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iomeprol in arteriosclerosis obliterans (2 arms), sponsored by Bracco Group. Primary endpoint: Average arterial contrast density in Hounsfield units. Started Dec 2005; status: completed.
02
Drugs
iomeprol
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2005-005946-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005946-38.